Among these, ZNF469 mutations were found to be targeted by neoantigen-specific T-cells in a long-term responder to CIT (44), while ANKRD27 and OTOF were identified as potential tumor-specific antigens for liver and kidney cancer, respectively (45). This evidence concerns the gene ZNF469 and kidney cancer.